Although a large number of immune cells are present around both the CMS1 and CMS4 subtypes, the CMS4 mesenchymal subtype seems to be more prone to an adverse inflammatory immunophenotype characterized by the activation of transforming factor TGF-β and enhanced tumor angiogenesis, tumor growth, and metastasis. The gene discussed is TGFB1; the disease is neoplasm.